MUC1-Activated T-Cells
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for MUC1-Activated T-Cells, covering 2026-03-16 to 2026-04-03. Get the full timeline:
Most recent: Clinical Trial Update: Genetically Engineered Cells (MUC1-Activated T-Cells) for the Treatment of MUC1 Positive Recurrent or Refractory Multiple Myeloma [Phase 1]